Patients with type-2 diabetes were able to follow the Ornish program and show the same improvements in coronary risk factors and quality of life as those without diabetes. Patients showed statistically significant decreases in their HgbA1c, and many were able to reduce or even discontinue their diabetes medications under their doctor’s supervision.
With better clinical outcomes, larger cost savings, bigger changes in lifestyle, and higher adherence and engagement, lifestyle medicine is reimbursed by Blue Shield of California, Medicare, Aetna, and many other commercial payers.
Press Release with Blue Shield of CaliforniaReimbursement
Medicare
Blue Shield of California
Aetna
Join our list to receive sample recipes, our latest research and related resources!